2018 International Congress » Surgical Therapy: Parkinson's Disease

Date: Saturday, October 6, 2018

Time: 1:45pm-3:15pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:45pm-3:15pm: 8-Contact Multiple Independent Current Control vs. 4-Contact Standard Deep Brain Stimulation of Subthalamus in Parkinson’s disease: a Double-blind Cross-over Trial

D. Soh, M. Algarni, R. Munhoz, A. Lozano, S. Kalia, M. Hodaie, A. Fasano (Toronto, ON, Canada)

1:45pm-3:15pm: A Patient-Centered Decision-Making Algorithm for Deep Brain Stimulation Surgery in Parkinson’s Disease

S. Joza, K. Yen, F. Ba, J. Miyasaki (Edmonton, AB, Canada)

1:45pm-3:15pm: A prospective MRI study of edema surrounding deep brain stimulation leads

L. Borellini, F. Cogiamanian, S. Sbaraini, E. Scola, G. Carrabba, M. Locatelli, S. Avignone, F. Mameli, F. Ruggiero, R. Ferrucci, G. Ardolino, S. Barbieri, P. Rampini (Milano, Italy)

1:45pm-3:15pm: A wireless brain-spine interface alleviating gait deficits of non-human primates model of Parkinson’s disease

F. Raschella, T. Milekovic, M. Perich, S. Sun, G. Schiavone, C. Hitz, Y. Jianzhong, W. Ko, Q. Li, C. Qin, S. Lacour, J. Bloch, S. Micera, E. Bezard, G. Courtine (Geneva, Switzerland)

1:45pm-3:15pm: An Objective Tool to Guide Target Selection for DBS in PD (GPi vs STN) – integration into Thomas Jefferson’s multidisciplinary Movement Disorders Center

L. Meytin, TW. Liang, J. Ratliff (Philadelphia, PA, USA)

1:45pm-3:15pm: Attitudes toward earlier use of deep brain stimulation among patients with Parkinson’s disease

L. Cabrera, C. Sidiropoulos (East Lansing, MI, USA)

1:45pm-3:15pm: Beneficial nonmotor effects of subthalamic and pallidal DBS in Parkinson’s disease

H. Dafsari, M. dosSantos Ghilardi, V. Visser-Vandewalle, A. Rizos, K. Ashkan, M. Silverdale, J. Evans, R. Martinez, R. Cury, M. Barbe, G. Fink, A. Antonini, K. Ray-Chaudhuri, P. Martinez-Martin, E. Fonoff, L. Timmermann (Cologne, Germany)

1:45pm-3:15pm: Blinded acute assessment of electrode contact efficacy compared with contact location for Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease

G. Lim, B. Jonker, S. Bolitho, S. Tisch (Sydney, Australia)

1:45pm-3:15pm: Can brittle dyskinesia be one of the causes of Twiddler syndrome in Deep Brain Stimulation?

A. Acarer, H. Biçeroğlu, T. Yurtsever, Z. Çolakoğlu (Izmir, Turkey)

1:45pm-3:15pm: Change of tremor dominant body side after deep brain stimulation in patients with Parkinson’s disease

P. Wouters, M. Janssen, P. Kubben, L. Ackermans, Y. Temel, M. Kuijf (Maastricht, Netherlands)

1:45pm-3:15pm: Choice for deep brain stimulation in Parkinson’s disease: Italian survey study

R. Ferrucci, C. Di Nuzzo, F. Ruggiero, F. Mancini, A. Priori (Milan, Italy)

1:45pm-3:15pm: Comparative results between preoperative acute levodopa challenge test and deep brain stimulation

D. Fitas, M.J. Rosas, J. Parada Lima, C. Reis, P. Linhares, R. Vaz (Viana do Castelo, Portugal)

1:45pm-3:15pm: Comparison of low-frequency stimulation versus high-frequency stimulation of the subthalamic nucleus on cerebral hemodynamics in Parkinson’s disease: A transcranial Doppler Study

A. Yilmaz, E. Okuyucu, T. Yildizgoren, S. Oral, M. Aras, Y. Serarslan (Hatay, Turkey)

1:45pm-3:15pm: Comparison of Mattis and MOCA testing for neuropsychological assessment in the preoperative evaluation of subthalamic nucleus stimulation in Parkinson´s disease

L. Prilop, M. Alsalem, A. Gulberti, C. Gerloff, C. Buhmann, W. Hamel, C. Moll, J. Köppen, M. Pötter-Nerger (Hamburg, Germany)

1:45pm-3:15pm: Controlled neural organoids grafting promotes functional recovery in experimental parkinsonism

E. Faggiani, M. Feyeux, K. Alessandri, P. Cohen, E. Pioli, F. Naudet, A. Benazzzouz, P. Nassoy, E. Bezard (Bordeaux, France)

1:45pm-3:15pm: Could the rate of dopaminergic medications reduction affect outcome after STN-DBS?

S. Alusi (Liverpool, United Kingdom)

1:45pm-3:15pm: Deep brain stimulation and its efficacy using microelectrode recording

V. Rama Raju, R. Borgohain (Hyderabad, India)

1:45pm-3:15pm: Deep brain stimulation for monogenic Parkinson’s disease: A systematic review

T. Kuusimäki, J. Korpela, E. Pekkonen, M. Martikainen, A. Antonini, V. Kaasinen (Turku, Finland)

1:45pm-3:15pm: Deep brain stimulation in Parkinson’s disease: From the stimulation of a nucleus to the stimulation of neuronal networks

A. Arévalo, L. López Manzanares, R. Manzanares, M.A. García-Pallero, M. Navas, P. Pastor, L. Vega Zelaya, CV. Torres Diaz. (Madrid, Spain)

1:45pm-3:15pm: Directional DBS; clinical experience at Unit of Functional Neurosurgery. Ramón y Cajal University Hospital,Madrid, Spain

M. del Alamo, I. Martinez-Camacho, L. Cabañes, I. Regidor, M. Villadoniga, J. Garcia-de-la-Cruz, I. Avilés-Olmos (Madrid, Spain)

1:45pm-3:15pm: Directional DBS: A new algorithm to determine lead rotation

T. Dembek, M. Barbe, A. Hellerbach, M. Hoevels, J. Wirths, A. Horn, V. Visser-Vandewalle, H. Treuer (Cologne, Germany)

1:45pm-3:15pm: Directional deep brain stimulation in Parkinson’s disease guided by local field potentials

F. Alonso-Frech, C. Fernandez-Garcia, M. Monge, M.J. Catalan Alonso, G. Foffani (Madrid, Spain)

1:45pm-3:15pm: Distance to white matter tracts predicts STN deep brain stimulation outcome of tremor and dysarthria in Parkinson’s disease

L. Boon, N. Prent, W. Potters, M. Caan, H. Berendse, R. de Bie, P. vd Munckhof, P. Schuurman, A. van Rootselaar (Amsterdam, Netherlands)

1:45pm-3:15pm: Dopaminergic medication changes affect cognitive, mood, and quality of life outcomes after STN DBS

D. Floden, O. Hogue, M. Saupe, R. Busch, K. Wilson, A. Ahmed (Cleveland, OH, USA)

1:45pm-3:15pm: Dyskinesia-hyperpyrexia syndrome (DHS) after sudden interruption of deep brain stimulation and increase of oral dopaminergic therapy: A case report

F. Dematteis, A. Cormio, C. Fronda, M. Lanotte, M. Zibetti, S. Amarù, L. Lopiano, M. Rizzone (Rivoli, Italy)

1:45pm-3:15pm: Effect of Post-Operative Symptomatic Lead Edema Associated with Subthalamic Deep Brain Stimulation On Clinical Outcomes

V. Sharma, K. Lyons, J. Nazzaro, R. Pahwa (Kansas City, KS, USA)

1:45pm-3:15pm: Effects of MRI-guided Focused Ultrasound unilateral subthalamotomy on characteristics of EMG activity underlying reaction time and tapping test in Parkinson’s disease

D. Urso, B. Fernández-Rodríguez, R. Rodríguez-Rojas, M. del Álamo, F. Hernández-Fernández, J. Pineda-Pardo, M. Dileone, G. Foffani, I. Obeso, C. Gasca-Salas, L. Vela, R. Martínez-Fernández, F. Alonso-Frech, J. Obeso (Móstoles, Spain)

1:45pm-3:15pm: Efficacy and safety of combined unilateral subthalamic nucleus and contralateral globus pallidus deep brain stimulation in Parkinson’s disease

N.R. Choi, K.W. Park, H.S. Ryu, M.S. Kim, S.J. Chung (Seoul, Republic of Korea)

1:45pm-3:15pm: Estimates of cost and saving effects of increasing rechargeable devices on the sustainability of a deep brain stimulation program

Y. Compta, A. Cámara, P. Roldán, E. Muñoz, J. Rumià, MJ. Marti, F. Valldeoriola (Barcelona, Catalonia)

1:45pm-3:15pm: Evaluation of apathy before and after subthalamic nucleus deep brain stimulation therapy in advanced Parkinson’s disease patients

S. Caferova, O. Gönül, D. Gunal (Istanbul, Turkey)

1:45pm-3:15pm: Gradient-like representation of emotional valence and arousal within the subthalamic nucleus in Parkinson’s disease

T. Serranová, T. Sieger, F. Růžička, E. Bakštein, P. Dušek, P. Vostatek, D. Novák, E. Růžička, D. Urgošík, R. Jech (Prague, Czech Republic)

1:45pm-3:15pm: Hardware-related infections seen after implantable pulse generator replacement in Parkinson‘s patients who underwent Deep Brain Stimulation: A Single Center Experience

A. Acarer, H. Biçeroğlu, E. Özgiray, Z. Çolakoğlu (Izmir, Turkey)

1:45pm-3:15pm: Hemidystonia due to midbrain hemorrhage: An unusal complication of Deep Brain Stimulation

G. Sciacca, S. Bonvegna, F. Dematteis, M. Lanotte, A. Romagnolo, L. Lopiano, U. Dimanico, M. Rizzone (Catania, Italy)

1:45pm-3:15pm: Impact of changes in resistance on current delivered in constant voltage DBS stimulator in Parkinson’s Disease

S. Meka, T. Syed, S. Kumar, S. Tandra, R. Kandadai, S. Turaga, R. Borgohain (Hyderabad, India)

1:45pm-3:15pm: Impact of Disease Duration and Anatomical Target on Health Related QoL in Patients Receiving DBS: Results from the Product Surveillance Registry

M. Schiess, S. Falowski, S. Palfi, J. Azulay, A. Lopez-Rios, L. Defebvre, J. Espinoza, K. Sandberg, B. Van Dorn, T. Weaver, P. Konrad, J. Krauss (Houston, TX, USA)

1:45pm-3:15pm: Impact of electrode impedance changes in clinical outcomes of patients with Parkinson’s disease and subthalamic nucleus deep brain stimulation

ME. Contreras Pinto, J. Martins, C. Cerquera, S. Dias, D. Giraldo Salazar, JS. Saavedra Moreno, F. Vallderiola Serra (La Serena, Chile)

1:45pm-3:15pm: Impact of STN-DBS on Medication Reduction

M. Carmona-Abellán, G. de Ulibarri, J. Guridi, P. Clavero, M. Alegre, R. Luquin-Piudo (Pamplona, Spain)

1:45pm-3:15pm: Impact of Subthalamic Nucleus Stimulation on Striatal Dopamine Transporter in Parkinsonian Rat Models

W. Xian, Q. Guo, L. Jiang, Z. Pei, L. Chen (Guangzhou, China)

1:45pm-3:15pm: Intraoperative Electromyography can optimize pallidotomy for Parkinson’s disease and dystonias

P. Brainer, A. Campos, A. Brainer, J. Brainer, P. Brainer, P. Coutinho, C. Lima, S. Laurentino, R. Bandin, M. Andrade (Recife, Brazil)

1:45pm-3:15pm: Intraparenchymal Cyst Formation: A Rare Complication of Deep Brain Stimulation

K. Tan, C. Zadikoff (Chicago, IL, USA)

1:45pm-3:15pm: Is lowering stimulation frequency a feasible option to improve speech in Parkinson’s disease patients undergoing subthalamic deep brain stimulation?

M. Fabbri, M. Zibetti, G. Ferrero, A. Accornero, I. Guimaraes, M. Rizzone, A. Romagnolo, J. Ferreira, L. Lopiano (Lisbon, Portugal)

1:45pm-3:15pm: Long Term Outcome of the Subthalamic Nucleus DBS for Advanced Parkinson’s Disease: An Eight Years Follow-Up Study in China

Q. Guo, J. Liu, C. Yang, W. Xian, L. Jiang, S. Xu, W. Chen, Y. Hu, L. Chen (Guangzhou, China)

1:45pm-3:15pm: Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD

T. Xie, L. Bloom, M. Padmanaban, B. Bertacchi, W. Kang, A. Dachman, E. MacCracken, C. Zadikoff, K. Markopoulou, P. Warnke, U. Kang (Chicago, IL, USA)

1:45pm-3:15pm: Malignant neuroleptic syndrome following a sudden deep brain stimulation battery drain: Report of two cases

O. Yilmaz Kusbeci, A. Acarer, Y. Unsal, Z. Colakoglu, R. Bilgin (Izmir, Turkey)

1:45pm-3:15pm: Microelectrode recording for optimization of the long-term outcome in subthalamic deep brain stimulation for Parkinson’s disease

A. Gamaleya, A. Tomskiy, A. Poddubskaya, S. Omarova, A. Dekopov, E. Salova, E. Bril, N. Fedorova (Moscow, Russian Federation)

1:45pm-3:15pm: Mild Cognitive Impairment in Parkinson’s Disease Before and After Deep Brain Stimulation

A. Troster, A. Abbott, F. Ponce, H. Shill, S. Oravivattanakul, G. Moguel-Cobos, N. Salins, A. Lieberman, K. Hanson (Phoenix, AZ, USA)

1:45pm-3:15pm: Mirthful laughter avoided by directional stimulation in a Parkinson’s disease patient treated with deep brain stimulation

F. Alonso-Frech, M. Monge, C. Fernandez-Garcia, C. Villanueva (MADRID, Spain)

1:45pm-3:15pm: Motor and cognitive progression in GBA-related PD patients submitted to Deep Brain Stimulation

L. Correia Guedes, C. Silva, R. Machado Bouça, N. Gonçalves, M. Fabbri, A. Castro Caldas, P. Pita Lobo, M.M. Rosa, B. Cattoni, H. Carvalho, A. Gonçalves Ferreira, J.J. Ferreira, M. Coelho (Lisbon, Portugal)

1:45pm-3:15pm: Nigral stimulation for the treatment of refractory gait disturbances in Parkinson’s disease

M. Carmona-Abellán, D. Moreno, M. Alegre, J. Guridi, R. Luquin (Pamplona, Spain)

1:45pm-3:15pm: Optimized Imaging at 3.0 T of the Rostral Zona Incerta (rZI) for Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)

A. Thaker, K. Reddy, J. Thompson, P. David-Gerecht, A. Abosch, D. Kern (Aurora, CO, USA)

1:45pm-3:15pm: Optimizing the Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) outcome in Parkinson’s disease patient with interleaving stimulation

C. Lau, C. Zhu, D. Chan, K. Ma, A. Chan, J. Yeung, V. Mok, W. Poon (Hong Kong)

1:45pm-3:15pm: Patient’s Choice of Device-Based Treatments in Parkinson’s Disease

M. Kuzu Kumcu, S. Tezcan Aydemir, Ç. Ulukan, B. Bakırarar, C. Akbostancı (Ankara, Turkey)

1:45pm-3:15pm: Poor responders to STN DBS in Parkinson’s disease: 1 year follow-up study

M. Zibetti, L. Ricciardi, E. Montanaro, M. Sarchioto, M. Edwards, L. Lopiano, F. Morgante (Toriino, Italy)

1:45pm-3:15pm: Post-Deep Brain Stimulation Psychosis in Parkinson’s Disease: A Meta-analysis

YC. Tai, N. Mahant, B. Stubbs, A. Carvalho, YW. Chen, TY. Chen, SP. Hsu, PT. Tseng (Kaohsiung, Taiwan)

1:45pm-3:15pm: Practice patterns, motor outcomes and health disparities in patients undergoing Deep Brain Stimulation for Parkinson’s disease

C. Luca, D. Garbin diLuca, H. Moore, C. Singer, I. Cajigas, J. Jagid (Miami, FL, USA)

1:45pm-3:15pm: Predicting patient risk and discharge disposition subsequent to deep brain stimulation surgery

F. Farrokhi (Seattle, WA, USA)

1:45pm-3:15pm: Predictor for speech deterioration following STN-DBS in PD patients

Y. Tanaka, T. Tsuboi, H. Watanabe, D. Nakatsubo, S. Maesawa, S. Kato, Y. Kajita, M. Sato, R. Odake, M. Hattori, M. Yamamoto, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)

1:45pm-3:15pm: Programming for Freezing of gait after Bilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease

H. Zheng, F. Sun, L. Zhang (Nanjing, China)

1:45pm-3:15pm: Propionibacterium acnes Infection with Intracerebral Abscess in Deep Brain Stimulation

R. Lewis, F. Farrokhi, M. Marsans (Seattle, WA, USA)

1:45pm-3:15pm: Pulvinar low intensity on susceptibility-weighted imaging may predict cognitive worsening after deep brain stimulation therapy in Parkinson’s disease patients

K. Matsuura, M. Maeda, M. Satoh, K. Tabei, T. Araki, M. Umino, H. Kajikawa, N. Nakamura, H. Tomimoto (Tsu, Mie, Japan)

1:45pm-3:15pm: Simple Programming Method in STN-DBS using directional lead

K. Kimura, H. Kishida, T. Kawasaki, K. Hamada, N. Ueda, F. Tanaka (Yokohama, Japan)

1:45pm-3:15pm: Single centre experiences of directional leads in Parkinson patients

U. Scheller, G. Wenzel, R. Lofredi, D. Kroneberg, K. Faust, G.H. Schneider, A.A. Kühn (Berlin, Germany)

1:45pm-3:15pm: Spontaneous peri-electrode edema, 7 years after subthalamic nucleus deep brain stimulation (STN-DBS) in a patient with Parkinson´s disease (PD): A case report

O. Morsi, J. Lopez, J. Jimenez, L. Fuentes, G. Valero, A.E. Baidez, E. Andreu (Murcia, Spain)

1:45pm-3:15pm: STN-DBS causing persistent dyskinetic movements in OFF-State

J. Muellner, J. Michelis, L. Lachenmayer, K. Petermann, I. Debove (Bern, Switzerland)

1:45pm-3:15pm: Subthalamic deep brain stimulation is safe and effective treatment for elderly patients with Parkinson’s disease

J. Youn, M. Kim, JH. Park, K.R. Cho, J.H. Ahn, JI. Lee, J.W. Cho (Seoul, Republic of Korea)

1:45pm-3:15pm: Subthalamic neuromodulation restores motor learning in Parkinson’s disease

A.L. Marcelino, A. Horn, A. Kühn, W.J. Neumann (Berlin, Germany)

1:45pm-3:15pm: Subthalamic nucleus deep brain stimulation evoked neural activity predicts clinical response to DBS

S. Xu, N. Sinclair, K. Bulluss, T. Perera, W. Lee, H. McDermott, W. Thevathasan (East Melbourne, Australia)

1:45pm-3:15pm: Surgery-, hardware – and chronic stimulation-related adverse events following subthalamic nucleus deep brain stimulation for Parkinson’s disease

B. Gonenli Kocer, E. Ozturk, S. Comoglu, M. Sorar, H. Kertmen (Ankara, Turkey)

1:45pm-3:15pm: Swimming in PD patients with STN-DBS: A pilot exploratory study

D. Flisar, S. Ibrulj, M. Trošt, M. Benedičič, P. Mušič, S. Korelc, K. Groleger Sršen (Ljubljana, Slovenia)

1:45pm-3:15pm: Symptom specified target and procedure selection for Parkinson’s disease: A case report

W. Linbin, L. Dianyou, P. Yixin, Z. chencheng, S. Bomin (Shanghai, China)

1:45pm-3:15pm: Teed and primary cell longevity: Results from product surveillance registry

P. Konrad, G. Plotkin, S. Palfi, E. Cuny, J-P. Azulay, T. Witt, T. Theys, Y. Temel, G. Johnson, K. Bhatia, T. Weaver, M. Schiess, J. Krauss, S. Falowski (Nashville, TN, USA)

1:45pm-3:15pm: The change of heart rate variability after subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease: A Meta⁃analysis

X.Y. Luo, R. Ou, H.F. Shang (Chengdu, People’s Republic of China)

1:45pm-3:15pm: The effects of deep brain stimulation of the pedunculopontine nucleus on cognition in Parkinson’s disease and Progressive Supranuclear Palsy

F. Leimbach, J. Gratwicke, T. Foltynie, M. Hariz, P. Limousin, L. Zrinzo, M. Jahanshahi (London, United Kingdom)

1:45pm-3:15pm: The efficacy and safety of STN-DBS under general anesthesia for PD patients

W. Chen, L. Chen (Guangzhou, China)

1:45pm-3:15pm: Toe dystonia in Parkinson’s disease: Impact of subthalamic nucleus deep brain stimulation

C. Laurencin, S. Montaut, T. Danaila, C. Vial, S. Thobois (Lyon, France)

1:45pm-3:15pm: Weight loss in STN DBS in Parkinson’s Disease? Long-term outcome of a prospective cohort at 5 years

D. Chan, C. Chan, A. Chan, C. Lau, C. Zhu, W. Poon, V. Mok (Hong Kong, Hong Kong)

« View all sessions from the 2018 International Congress.